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Thyroglobulin as a Functional Biomarker
of Iodine Status in a Cohort Study of Pregnant Women
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Background: Though iodine deficiency in pregnancy is a matter of public-health concern, a functional measure of
iodine status is lacking. The thyroid-specific protein thyroglobulin (Tg), which reflects thyroid size, has shown
promise as a functional measure in studies of children and adults, but data in pregnancy are sparse. In a cohort of
mildly to moderately iodine-deficient pregnant women, this study aimed to explore whether serum Tg is a
sensitive functional biomarker of iodine status and to examine longitudinal change in Tg with gestational age.
Method: A total of 230 pregnant women were recruited at an antenatal clinic at 12 weeks of gestation to the
Selenium in PRegnancy INTervention study, in Oxford, United Kingdom. Repeated measures of urinary iodine-
to-creatinine ratio, serum thyrotropin (TSH), and Tg at 12, 20, and 35weeks of gestation weremade.Womenwere
dichotomized by their iodine-to-creatinine ratio (<150 or ‡150lg/g) to group them broadly as iodine deficient or
iodine sufficient.Womenwith thyroid antibodies were excluded; data and samples were available for 191 women.
Results:Median Tg concentrations were 21, 19, and 23 lg/L in the first, second, and third trimesters, respectively.
In a linear mixed model, controlling for confounders, Tg was higher in the <150lg/g group than it was in the
‡150lg/g group ( p < 0.001) but there was no difference in TSH ( p= 0.27). Gestational week modified the effect
of iodine status on TSH ( p= 0.01) and Tg ( p= 0.012); Tg did not increase with gestational week in the ‡150lg/g
group, but it did in the <150lg/g group, and TSH increased more steeply in the <150lg/g group.
Conclusions: Low iodine status (<150lg/g) in pregnancy is associated with higher serum Tg, suggesting that the
thyroid is hyperstimulated by iodine deficiency, which causes it to enlarge. Tg is a more sensitive biomarker of
iodine status in pregnancy than is TSH.
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Introduction
An adequate dietary supply of iodine is essential forthe production of the thyroid hormones thyroxine (T4)
and triiodothyronine (T3). Hence, the recent recognition that
the iodine status of teenage schoolgirls (1), women of child-
bearing age (2,3), and pregnant women (4–6) in the United
Kingdom appears to be suboptimal has raised concern. The
finding of an association between the mild-to-moderate de-
gree of iodine deficiency found in British pregnant women
and lower IQ and reading scores in their eight- to nine-year-
old children (7) has increased that concern.
Iodine status is commonly assessed by measurement of
urinary iodine concentration (UIC) from a spot-urine sample
(8). However, UIC is not a functional biomarker of iodine
status; it only reflects recent intake (past 24–48 h) and may
therefore not be representative of usual intake in an indi-
vidual. Although the thyroid hormones (T3 and T4) and
thyrotropin (TSH) are functional measures, they are not
sensitive markers of iodine status, as values can remain in the
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normal reference range in individuals with suboptimal iodine
intake because of tight homeostatic regulation (9). By con-
trast, the thyroid-specific protein thyroglobulin (Tg) shows
promise as a functional biomarker of iodine status that better
reflects long-term iodine intake (weeks or months) (8,9).
Serum Tg concentration is considered to reflect thyroid vol-
ume in both iodine-deficient and iodine-excessive settings
(10). In iodine deficiency, high Tg concentration results from
TSH stimulation of the thyroid, leading to thyroid enlarge-
ment (9). Antibodies to Tg (TgAb) can interfere with Tg
measurement, resulting in either a higher Tg concentration
when measured by radioimmunometric assay (RIA) or a
lower concentration when measured by an immunometric
assay (11). TgAb therefore need to be measured concurrently
so that those individuals who are TgAb-positive can be
excluded from analysis.
While studies have explored the relationship between
iodine status and serum Tg in both adults and children
(10,12), there is little exploration of this relationship in
pregnancy (9), especially with a repeated-measure study
design. Furthermore, there are no Tg data from pregnant
women in the United Kingdom—a region of mild-to-
moderate iodine deficiency. This study therefore aimed to
investigate the relationship between iodine status (as mea-
sured by the iodine-to-creatinine ratio) and serum Tg con-
centration in a cohort of British pregnant women to test
whether Tg might be a useful functional biomarker of low
iodine status and to understand the change in Tg concentra-
tion during pregnancy under conditions of mild-to-moderate
iodine deficiency.
The hypotheses of this study were that iodine status would
be negatively associated with serum Tg and that the associ-
ation would be stronger than with serum TSH. Furthermore, it
was hypothesized that the profile of TSH and Tg throughout
pregnancy would differ between those classified as iodine
deficient and iodine sufficient. A lag effect was anticipated
such that TSH would increase more steeply in iodine-
deficient women as pregnancy advanced and stores of iodine
became depleted.
Materials and Methods
This study used samples and data collected as part of the
Selenium in Pregnancy INTervention (SPRINT) study, a
double-blind placebo-controlled randomized trial (ISRCTN
37927591) that investigated the effect of selenium supple-
mentation on markers of risk of pre-eclampsia. Two hun-
dred and thirty primiparous women (sample size calculated
to detect differences in biological markers of pre-eclampsia)
were recruited when attending for an ultrasound scan at
12–14 weeks of gestation at the John Radcliffe Hospital
(Oxford, United Kingdom) between July 2009 and June 2011.
Relevant exclusion criteria were current smoking, being on
thyroid medication, and taking a selenium-containing sup-
plement. As most prenatal supplements contain both iodine
and selenium, this exclusion criterion meant that very few
women were taking an iodine-containing supplement (13).
One woman was recruited in error, as she was taking le-
vothyroxine and was therefore excluded. Full details of the
SPRINT study have already been reported (14).
This study was conducted according to the guidelines laid
down in the Declaration of Helsinki, and all procedures in-
volving human subjects were approved by the Milton Keynes
Research Ethics Committee (REC ref no. 08/H0603/46).
A non-substantial amendment for additional laboratory
measurements in stored samples was approved by NRES
Committee South Central Berkshire ( July 27, 2011). Written
informed consent was obtained from all subjects.
Procedures
Blood and urine samples were collected at approximately
12, 20, and 35 weeks of gestation. TSH, free T4 (fT4), and
thyroid peroxidase antibodies (TPOAb) were measured in
serum samples using a Modular Analytics E170 analyzer
(Roche Diagnostics, Mannheim, Germany) at the Department
of Clinical Chemistry, Ma´xima Medical Center (Veldhoven,
The Netherlands). Tg and TgAb were measured using an
electrochemiluminescence immunoassay on a Cobas e601
analyzer (Roche Diagnostics) at the Ma´xima Medical Center.
The serum Tg assay was calibrated against the Certified Re-
ference Material for human Tg (CRM-457). TPOAb concen-
trations >35 IU/mL and TgAb >115KIU/L (manufacturer’s
cutoff) were considered as positive for TPOAb and TgAb,
respectively. Women were defined as thyroid-antibody posi-
tive if they were positive for TPOAb and/or TgAb. The use of
trimester- and method-specific reference ranges from an
iodine-sufficient and thyroid-antibody negative population are
recommended for thyroid function tests in pregnancy (15).
However, no method-specific (i.e., Roche) reference ranges
exist in the literature (16). Trimester-specific reference ranges
for TSH and fT4 derived from women without thyroid auto-
immunity from an iodine-sufficient regionwere therefore used
(17). The reference ranges and the definitions of overt hypo-
thyroidism, hyperthyroidism, subclinical hypothyroidism, and
isolated hypothyroxinemia are reported in our previous study
that had the same participants as the current study (18). For
assessment of Tg, a cutoff of 40lg/Lwas used to indicate high
Tg concentration based on previous research in adults and
children (9).
Measurement of urinary iodine and creatinine concentra-
tion was carried out at the Trace Element Unit, Southampton
General Hospital, as previously described (13). Briefly, io-
dine was measured using a dynamic reaction cell inductively
coupled plasma mass spectrometry (ICP-MS), and certified
reference materials were used to ascertain the accuracy of the
method. Creatinine was measured using the UniCel DxC
Synchron Clinical System Analyzer by the Jaffe rate method.
The iodine-to-creatinine ratio was used in preference to the
UIC, as SPRINTwomenwere requested to attend the hospital
with a full bladder for their ultrasound scan, and as a result,
some urine samples were very dilute; use of the UIC would
have overstated iodine deficiency in the cohort (13).
Two hundred and nineteen women (95.6% of the cohort)
completed a Food Frequency Questionnaire (FFQ) at ap-
proximately 12 weeks of gestation (13), and data on milk
intake from the FFQ were used to explore the association
with serum Tg concentration. Our previous study in this
cohort found an association between milk intake and the
urinary iodine-to-creatinine ratio (13).
Statistical analysis
As the selenium intervention had no effect on urinary
iodine-to-creatinine ratio (13), TSH, or fT4 in antibody-
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negative women in the trial (18), data were pooled to analyze
the women as one group, regardless of intervention.
There is a known effect of autoimmune thyroid disease on
TSH (19), and TgAbs can interfere with the interpretation of
Tg analysis (9). Therefore, women who were positive for
TPOAb and/or TgAb at 12 weeks of gestation (n = 34; 14.9%)
and those with overt thyroid disease (one woman [0.4%] had
overt hyperthyroidism at 12 weeks of gestation) were ex-
cluded in order to describe more accurately the relationship
between iodine status and thyroid function. Two additional
women with a urinary iodine-to-creatinine ratio >700 lg/g
who were clear outliers (i.e., values suggestive of excessive
iodine intake) were excluded, and one woman with transient
subclinical hyperthyroidism at 12 weeks was also excluded,
as inclusion prevented convergence of the linear mixed
models. This left 191 women for statistical analysis.
Women were dichotomized on the basis of maternal uri-
nary iodine-to-creatinine ratio as ‡150lg/g (i.e., sufficient)
or <150lg/g (i.e., deficient), as in our previous study (7). The
groups were further divided by iodine-to-creatinine ratio as
<100, 100–149, 150–249, and ‡250 lg/g, based on method-
ology in a Belgian study (20).
Normally distributed data (fT4) are reported as mean
(standard deviation [SD]). Non–normally distributed data
(UIC, iodine-to-creatinine ratio, TSH, and Tg) were trans-
formed using the natural logarithm. TSH and Tg values are
reported as geometric means and confidence intervals [CI] by
back-transformation into the original units. The study com-
pared (log) Tg concentration between antibody-positive and
antibody-negative women, and between categories of milk
consumption using t-tests and one-way analysis of variance,
respectively. The chi-square test was used for comparison of
categories of milk intake and percentage of women with Tg
>40 lg/L.
A linear mixed model was used to maximize the utilizable
data, as some subjects had missing data. The predictors of
TSH and Tg were explored by building models that included
variables that are known to affect the concentration of
both (20). These variables were iodine-to-creatinine ratio
(<150 vs. ‡150 lg/g), gestational week, maternal age (years),
smoking status (ex-smoker vs. non-smoker), bodymass index
(BMI) at 12 weeks of gestation (kg/m2), and ethnicity
(Caucasian or other). Season (summer or winter) was also
included as a time-varying confounder to account for the
underlying change in season with progress of gestation, as
has been done previously (13). The model included random
effects, with random coefficients at the subject level (i.e.,
intercept and gestational week). A model was constructed
with an interaction term between the iodine variable and
gestational week, which allowed us to explore our hypothesis
that the effect of gestation would differ according to the io-
dine status of the individual. Interactions were tested between
the iodine variable and other confounders, but these were not
statistically significant. The standardized residuals at levels 1
(within-subject) and 2 (between-subjects) were visually as-
sessed for normality. The multivariable-adjusted geometric
mean ratios of TSH and Tg were estimated.
fT4 concentration was not modeled because the model
would not converge if the same linear mixed model was
applied as for the Tg and TSH variables (gestational week
could not be included as a random effect). It was therefore not
possible to evaluate the predictors of fT4 in the same way as
TSH and Tg, as the models were not comparable. Further-
more, there are known problems with fT4 measurement in
pregnancy that suggest that the measure may not be reliable
(21).
Statistical analysis was conducted using IBM SPSS Sta-
tistics for Windows v21.0 (IBM Corp., Armonk, NY). Sta-
tistical significance was set at 5%.
Results
At week 12 of gestation, 25 (11%) women were TPOAb-
positive, 22 (9.9%) were TgAb-positive, of whom nine (3.9%)
had isolated TgAb positivity (i.e., not TPOAb-positive).
Geometric meanTg concentration was lower in the 34 (14.9%)
women who were positive for TgAb and/or TPOAb in the first
(16 vs. 21; p= 0.17), second (13 vs. 18; p= 0.12), and third
trimesters (13 vs. 21; p= 0.02). These women were excluded
from further analysis.
The demographic data for the whole cohort of 230 women
have been reported previously (14). In these 191 women, the
mean (SD) age was 30.6 (4.2) years, the mean BMI was 24.4
(4.1) kg/m2, and 92.1% were Caucasian. The group was
classified as mildly-to-moderately iodine deficient in all tri-
mesters, as previously reported (13) (Table 1). TSH increased
and fT4 concentration decreased over the course of pregnancy
(Table 1).
The median Tg concentration was 21 lg/L in the first tri-
mester (n = 185), 19 lg/L in the second trimester (n = 183),
and 23lg/L in the third trimester (n = 179; Table 1). In the
first, second, and third trimesters, 29 (15.7%), 16 (8.7%), and
Table 1. Thyroid Function Parameters and Urinary Iodine Concentrations in Pregnant Women
Negative for TPOAb and/or TgAb Without Overt Thyroid Disease
First trimester n Second trimester n Third trimester n
Gestational week of samplea,b 12 (9, 14) 190 20 (17, 23) 185 35 (30, 36) 178
Iodine concentration (lg/L)a,b 39.4 (23.3, 84.4) 190 55.4 (32.1, 103) 186 73.2 (44.7, 126.5) 177
Iodine/creatinine ratio (lg/g)a,b 104 (66, 172) 190 119 (82, 186) 186 127 (86, 184) 177
Tg (lg/L)a 21 (13, 33) 185 19 (12, 30) 183 23 (13, 33) 179
TSH (mU/L)a 1.3 (0.1, 4.2) 190 1.8 (0.4, 4.0) 185 2.0 (0.4, 5.4) 179
fT4 (pmol/L)a 15.1 (1.8) 190 12.6 (1.4) 185 11.2 (1.4) 179
aValues are expressed as median (25th, 75th percentile) for iodine concentration, iodine-to-creatinine ratio, and Tg; fT4 values are
expressed as mean (SD); TSH and gestational week are expressed as median (min, max).
bValues differ from reference 13, as women with thyroid dysfunction are excluded here.
TPOAb, thyroid peroxidase antibodies; TgAb, thyroglobulin antibodies; Tg, thyroglobulin; TSH, thyrotropin; fT4, free thyroxine.
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33 (18.4%) women, respectively, had a high Tg, defined as a
concentration >40lg/L according to the reference range
suggested in studies of schoolchildren and adults (9).
A linear mixed model was constructed to explore the effect
of iodine status and gestational week on both TSH and Tg
while controlling for season, maternal age, smoking status,
BMI, and ethnicity. The interaction term between the iodine
variable (<150 and ‡150 lg/g) and gestational week was
significant in both the TSH ( p = 0.010) and Tg ( p = 0.012)
models. To interpret the effect of the iodine-status group
on Tg and TSH concentration, estimated marginal means
were reported while holding the continuous interacting
variable, gestational week, at the mean. Tg was significantly
( p < 0.001) higher in the <150 lg/g group compared with the
‡150lg/g group (estimated marginal mean 18 vs. 16lg/L;
p < 0.001). By contrast, there was no significant difference in
TSH concentration between the <150 and ‡150lg/g groups
at the mean gestational week (estimated marginal mean TSH
1.49 vs. 1.55mIU/L; p= 0.27).
The interaction between gestational week and the di-
chotomized iodine variable meant that there was no sig-
nificant increase in Tg with advancing pregnancy in the
‡150lg/g group, whereas there was an increase in Tg in
the <150 lg/g group (Fig. 1 and Table 2). Tg was higher in the
<150lg/g group than it was in the ‡150lg/g at each time
point of gestation, but the difference between the groups was
greater in the later stages of pregnancy (Table 3). TSH in-
creased with advancing gestation in both iodine-status
groups, but the increase was greater in the <150 lg/g group
than it was in the 150 lg/g group (Table 2).
When the four iodine-status groups (<100, 100–149, 150–
249, and ‡250lg/g) were explored, there was no significant
interaction between the iodine variable and gestational week
on either TSH ( p= 0.07) or Tg ( p = 0.054) concentration
(likely because of reduced power with a smaller sample size
in each group). Therefore, only main effects are reported.
While there was no difference in TSH concentration between
the four groups ( p = 0.25), Tg concentrations differed sig-
nificantly ( p < 0.001; Fig. 2). Women in the <100lg/g and
100–149 lg/g groups had significantly higher Tg concentra-
tions than those in the 150–249 and the ‡250lg/g groups
(Fig. 2). Against the reference group of 150–249lg/g, the
geometric mean ratio of the Tg concentration was 17% higher
in the <100lg/g group (1.17, [CI 1.10–1.25]) and 10% higher
in the 100–149lg/g group (1.10 [CI 1.03–1.17]). There was
no significant difference between the >250lg/g group
and the 150–249 lg/g group (Supplementary Table S1;
Supplementary Data are available online at www.liebertpub
.com/thy).
The study explored whether dietary intake of milk was
associated with Tg concentration at 12 weeks of gestation
(i.e., when the FFQ was completed). An inverse relationship
was found between Tg concentration and milk intake, such
that median Tg was lowest in the top milk-intake group
FIG. 1. Change in thyroglobulin
(Tg) throughout gestation according
to iodine-status group. Predicted
values for Tg based on median at
baseline and geometric mean ratio
for a one-week increase in the
<150lg/g group (solid line) and
the ‡150lg/g group (dashed line).
Results are from a linear mixed
model (on log-transformed data),
controlling for the effects of season
(winter/summer), body mass index
(<25 vs. ‡25kg/m2), smoking status
(never vs. ex-smoker), ethnicity
(Caucasian vs. other), and maternal
age. The interaction between iodine
status and gestational week was
significant ( p= 0.012).
Table 2. Linear Mixed Model Exploring the Interaction Between Iodine Status
and Week of Gestation on TSH and Tg Concentrations
TSH Tg
Urinary iodine-to-creatinine
ratio group
Geometric
mean ratio [CI]a
p-Value for
interactionb
Geometric
mean ratio [CI]a
p-Value for
interactionb
One week increase
in gestation
<150lg/g 1.020 [1.016–1.023] 0.010 1.006 [1.003–1.008] 0.012
‡150lg/g 1.011 [1.001–1.021] 0.999 [0.992–1.007]
aExponential of b from linear mixed model, controlling for the effects of season (winter/summer), body mass index (<25 vs. ‡25 kg/m2),
smoking status (never vs. ex-smoker), ethnicity (Caucasian vs. other), and maternal age.
bp-Value for the difference in slope (<150 vs. ‡150lg/g).
CI, confidence interval.
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(i.e., 24, 21, and 18 lg/L in the <140mL, 140–280mL, and
>280mL/day groups, respectively; p = 0.13). The difference
between those in the <140mL group and those in the
>280mL group was significant at the 90% level ( p = 0.06).
Milk consumption was significantly inversely associated
with the percentage of women with high Tg ( p = 0.02), with
28.3%, 12.2%, and 8.9% of women in the <140mL, 140–
280mL, and >280mL groups having a Tg concentration
>40 lg/L. There was no relationship between milk intake and
TSH (data not shown).
Discussion
In line with the hypothesis, a negative association was
found between iodine status (as measured by the iodine-to-
creatinine ratio) and serum Tg concentration. Tg was higher
in the group with an iodine-to-creatinine ratio <150 lg/g than
it was in the group with a ratio >150lg/g. Furthermore, when
the <150lg/g and the ‡150lg/g groups were subdivided,
there was a trend for increasing Tg concentration across the
four iodine-status groups, with the highest Tg concentration
Table 3. Tg Concentration in the First, Second, and Third Trimesters
of Pregnancy According to Iodine Group
Tg concentration (lg/L)a
12 weeks 20 weeks 35 weeks
Urinary iodine-to-creatinine
ratio group
<150 lg/g 17 [14–21] 18 [15–22] 20 [16–24]
‡150 lg/g 16 [13–20] 16 [13–20] 16 [13–20]
p-Valueb 0.056 <0.001 <0.001
aData are estimated marginal mean [CI]. Estimated marginal means are calculated from the linear mixed-model that controlled for the
effects of season (winter/summer), body mass index (<25 vs. ‡25 kg/m2), smoking status (never vs. ex-smoker), ethnicity (Caucasian vs.
other), and maternal age. It also included an interaction term between iodine group and gestational week. The estimated marginal means
were computed for these time points to reflect the study design.
bp-Value comparing the Tg concentration in the <150 and ‡150lg/g iodine group at each time point.
FIG. 2. Adjusted geometric mean TSH
and Tg concentration by iodine status
(as iodine-to-creatinine ratio, lg/g). The
error bars are the confidence intervals of the
geometric mean. Results are computed by
back transformation of estimated marginal
means from a linear mixed model (on
log-transformed data), controlling for the
effects of gestational week, season (winter/
summer), body mass index (<25 vs.
‡25 kg/m2), smoking status (never vs.
ex-smoker), ethnicity (Caucasian vs. other),
and maternal age. aSignificantly higher than
the 150–249 lg/g group ( p < 0.001) and the
‡250lg/g group ( p < 0.001). bSignificantly
higher than the 150–249 lg/g group
( p= 0.005) and the ‡250 lg/g group
( p= 0.002).
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being in those with an iodine-to-creatinine ratio <100 lg/g.
These results suggest that Tg may be used as a functional
marker of iodine deficiency in a mildly-to-moderately iodine
deficient population, and is a notably better marker than TSH.
The results also demonstrate that the effect of advancing
gestation on TSH and Tg differs between iodine-sufficient and
iodine-deficient women, as was hypothesized. The study
shows that in the <150lg/g group, the increase in TSH during
pregnancy was greater than it was in the ‡150lg/g group.
Furthermore, Tg concentration increased throughout preg-
nancy in the <150lg/g group, whereas there was no significant
change in the ‡150lg/g group. The difference in Tg con-
centration between the iodine groups was greatest in later
pregnancy. Taken together, these results suggest that even
mild-to-moderate iodine deficiency during pregnancy stresses
the thyroid. It should be remembered here that thyroid-
antibody positive women were excluded from the analysis,
which means that the Tg concentration was not influenced by
autoimmune destruction of thyroid cells.
The increase in TSH throughout gestation in both iodine-
status groups reflects the well-known physiological change
(15). In the first trimester, TSH is suppressed as a result of the
transient effect of human chorionic gonadotropin (hCG).
TSH then increases in the second and third trimesters (15).
However, the finding of a greater increase in TSH in the
<150lg/g group may reflect hyperstimulation of the thyroid
under conditions of iodine deficiency. The increase in Tg
concentration in the iodine-deficient women suggests that
thyroid volume is increasing as pregnancy advances. Initially
(first trimester), this is likely to be a result of hyperstimula-
tion of the thyroid by hCG, but the later increase probably
reflects thyroidal adaptation to the low dietary iodine supply.
It has previously been suggested that an increase in thyroid
size in pregnancy may be a risk factor for impaired supply of
thyroid hormones to the fetus and that the increased size may
not completely regress after pregnancy, leading to later thy-
roid dysfunction in the mother (22).
Randomized controlled trials (RCTs) in pregnant women
from regions of mild-to-moderate iodine deficiency have
found that iodine supplementation can prevent the increase in
thyroid size and Tg concentration seen in the control groups
with advancing pregnancy (23–25). The present results sup-
port the findings from those RCTs, as no increase in Tg was
found in the iodine-sufficient group (i.e., those with an
iodine-to-creatinine ratio ‡150lg/g).
Tg has shown promise as an iodine-status marker, and has
been used successfully, along with UIC, in schoolchildren
from different countries (12) and in adults in China (26). In a
recent RCT, Tg was shown to be responsive to improved
iodine status in adults following 24 weeks of iodine sup-
plementation (27). However, the potential for Tg to be a
longer-term biomarker of iodine status in pregnant women
has seldom been explored, and this is the first such study in
British women.
A strength of this study is that it used repeated measures for
both Tg and urinary iodine excretion in pregnant women.
Although two other studies also had repeated measures, they
either did not report the relationship between urinary iodine
status and Tg (28), or they only used simple cross-sectional
analysis at each trimester (29). Therefore, to the authors’
knowledge, this is the first study to use a repeated-measures
analysis to relate iodine status to Tg concentration and to
explore the change in Tg concentration during pregnancy in
relation to urinary iodine excretion. Other studies in preg-
nancy have measured iodine status and Tg at one time point
and have not found an association with either UIC (30,31)
(possibly as a result of small sample sizes) or with 24 h urine
excretion (32). However, two studies found a significant
negative association between UIC and Tg that was stronger
than the association between UIC and TSH (20,29). These
studies support the present findings. A recent review of Tg
found the median Tg to be ‡13 lg/L in the majority of studies
of pregnant women from iodine-deficient areas (27), as was
the case in our study of mildly to moderately deficient women
where the median Tg concentration was 21, 19, and 23 lg/L
in trimesters one, two, and three, respectively. There is evi-
dence, both from schoolchildren (12) and pregnant women
(33), that the relationship between UIC and Tg is U-shaped.
However, there was no evidence of non-linearity in this
study, probably because most women were deficient, and it
was therefore not possible to explore the effects of iodine
excess.
Low intake of milk, the major source of iodine in the
United Kingdom, was found to be associated with a higher Tg
concentration, suggesting that low iodine intake, either pre-
pregnancy or early in pregnancy (the FFQ reflected intake
over the previous 12 months), results in increased thyroid
size. This finding is similar to that from a study in Denmark
that found an association between a low iodine index (based
on milk and fish intake) and higher Tg concentration in adults
(males and females) (34). Furthermore, Danish pregnant
mothers who took an iodine-containing supplement had
significantly lower Tg levels at term (35).
The significant interaction found between iodine status and
gestational week suggests that simple cross-sectional analy-
sis may not reveal the relationship between iodine and TSH
because there may be a lag between inadequate iodine intake
and evidence of thyroid dysfunction. Indeed, when women
were dichotomized (<150 and ‡150 lg/g) according to their
iodine-to-creatinine ratio at 12 weeks, although there was no
difference in TSH concentration, which was also measured at
12 weeks, TSHwas higher at 20 ( p = 0.008) and 35 ( p = 0.06)
weeks of gestation in the women who were in the <150 lg/g
group at 12 weeks. This suggests a lag effect of low iodine
status on serum TSH, and might explain why previous studies
in pregnant women in iodine-deficient regions that have
only examined relationships cross-sectionally have not found
significant associations between iodine status and TSH
(6,30,36–40).
This study has a number of limitations. First, the women
were recruited as part of a trial, and therefore may be of
higher socioeconomic and educational status than the general
population. It has previously been shown that maternal edu-
cation is positively associated with iodine-to-creatinine ratio
in pregnant women in this and in another cohort (7,13).
Second, the study was conducted in a region of mild-to-
moderate iodine deficiency, reducing the ability to explore
the relationship between iodine and Tg across the full range
of iodine status. Third, women with thyroid antibodies were
excluded, and therefore the findings relate to ‘‘healthy’’
pregnant women without overt (or subclinical) thyroid dys-
function. Fourth, thyroid volume was not assessed by ultra-
sound, hence it was not possible to correlate higher Tg
concentration with thyroid size.
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In conclusion, Tg shows promise as a long-term marker of
iodine status in pregnant women. Amethod for measuring Tg
in dried blood spots (DBS) has recently been developed in
samples from pregnant women that may be useful in future
studies (41). However, the inter-assay variability (even if
calibrated to CRM-457) makes the determination of a general
clinical cutoff for Tg concentration challenging. Tg mea-
surement is invasive and an additional expense, but this study
suggests that urinary iodine excretion and Tg may be com-
plementary measures of iodine status and may give a better
picture of status than either measure alone. Future studies
should therefore consider measurement of Tg concentration
(concurrently with TgAb, as 10% of women in this study
were TgAb-positive, which tended to decrease Tg) in addi-
tion to urinary iodine-to-creatinine ratio when assessing the
iodine status of pregnant women.
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